world. ahead on cnn newsroom, all eyes are on the sky. we re tracking the suspected chinese spy balloon flying across the united states. we ll have a live report on what the chinese are say ing about this incident. officials are advising people to stay indoors. if you go outdoors, be advised that exposed skin can get frostbite in as little as a few minutes. more than 20 million americans for impact from what wou could be the biggest cold snap of the season with windchills in new hampshire reaching negative 100 degrees fahrenheit. president biden previewing his platform for a possible 2024 reelection bid. this as the u.s. releases a blockbuster jobs number report. the u.s. military believes a suspected chinese supply balloon will finally leave u.s. air space in a couple days, or it could be sooner. some weather models show the winds pushing it out over the atlantic as early as today. the pentagon has been close let tracking the large object and concluded it s carrying a
Cantor Fitzgerald reiterated their neutral rating on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a research report report published on Thursday morning, Benzinga reports. They currently have a $128.00 target price on the biotechnology company’s stock. Other equities analysts also recently issued research reports about the company. Wedbush reissued an outperform rating and […]
Needham & Company LLC restated their buy rating on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a report published on Thursday morning, Benzinga reports. Needham & Company LLC currently has a $166.00 target price on the biotechnology company’s stock. SRPT has been the topic of several other research reports. TheStreet raised Sarepta Therapeutics […]
Sapient Capital LLC purchased a new stake in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 10,146 shares of the biotechnology company’s stock, valued at approximately $978,000. Several other institutional investors also recently bought […]
Mach 1 Financial Group LLC acquired a new position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 5,144 shares of the biotechnology company’s stock, valued at approximately $496,000. Several other hedge funds have also […]